JWEL Q3 2025 Earnings Report

Page 1

NEWS RELEASE Jamieson Wellness Inc. Reports Third Quarter 2025 Results 2025-11-06 Marketing and product innovations continue to drive high consumer engagement and double-digit revenue growth across the Company’s portfolio of leading consumer brands TORONTO--(BUSINESS WIRE)-- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its third quarter results for the period ended September 30, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other nancial measures. See “Non-IFRS and Other Financial Measures” below. Management Commentary “In Q3, Jamieson delivered another strong quarter with 16.5% branded growth and momentum across every major region,” said Mike Pilato, President and CEO. “In Canada, our marketing campaign featuring our product quality and Canadian-made message continues to resonate, driving growth and reinforcing trust in a market where we're the category leader. “In China, we grew our share position across all major digital platforms. Our evolving marketing strategy is delivering solid results, amplied by a diverse network of respected wellness inuencers. Jamieson was recently named VMS Store of the Year on Douyin, a social and e-commerce platform with over 700 million daily active users. It's a powerful endorsement of our brand strength and execution in one of the world's most dynamic consumer markets. “Youtheory continues to scale in the U.S., with strong growth in both digital and traditional channels. Product 1

Page 2

innovations, led by our new ashwagandha gummy, drove deeper consumer engagement with the brand. And internationally, we're seeing double digit growth in key markets led by the Middle East, with strong gains in Saudia Arabia where Jamieson is now a leading foreign brand. “Even against a volatile macro backdrop, our category continues to prove its resilience. VMS is increasingly central to how consumers care for themselves and their families, and with our diverse and growing branded platform, we're uniquely positioned to meet them - across geographies, across channels, and across life stages. I’m grateful to the entire Jamieson team for their expert execution, delivering exceptional results today and building long-term value for our shareholders.” Third Quarter Highlights Successful innovation and the Company’s recent quality-focused advertising campaign drove continued strong consumer consumption in Canada Digital e-commerce growth outpaced the market in China due to evolving inuencer marketing strategy, impacting all channels and resulting in over 60% revenue growth youtheory POS increased as the Company’s new digital e-commerce strategy continues to perform and traditional retail continues to grow International growth continued in key markets including Saudi Arabia, the Caribbean and Europe driven by new distribution and high consumer engagement Summary of Consolidated Results All comparisons are with the third quarter of 2024 Consolidated revenue increased 13.2% to $199.3 million, driven by 16.5% growth in Jamieson Brands, partially oset by an expected decline in Strategic Partners Gross prot increased by $16.0 million to $83.6 million, driven by higher branded revenue and margins Gross prot margin 3 increased by 350 basis points due to a higher proportion of growth in Jamieson Brands sales EBITDA 1 increased by $5.2 million to $33.1 million, mainly driven by higher revenues and gross prot; Adjusted EBITDA 1 increased by $4.1 million or 12.0% to $38.0 million, reecting the impact of higher sales volumes, partially oset by timing of investments in SG&A Net earnings was $15.5 million; Adjusted net earnings 1 was $17.7 million, or $1.8 million higher, reecting higher normalized earnings from operations Diluted earnings per share was $0.35; Adjusted diluted earnings per share 2 was $0.41 Summary of Segment Results 2

Page 3

All comparisons are with the third quarter of 2024 Jamieson Brands Revenue increased 16.5% or $25.5 million Canada revenue increased by 4.0%, largely reecting consumer consumption driven by the Company’s latest marketing campaign and innovations China revenue increased 63.0% primarily driven by successful digital performance marketing campaigns youtheory revenue increased by 16.8%, driven by continued strong consumption in e-commerce and growth in the Company’s traditional channels International revenue increased by 19.3%, driven by growth in core markets in the Middle East through innovation and distribution gains Gross prot increased by $16.0 million to $81.3 million, mainly driven by revenue growth and higher margins Gross prot margin 3 increased by 290 basis points, mainly driven by higher branded volumes in China, the Company’s highest margin business Adjusted EBITDA 1 increased by $4.1 million to $36.5 million, driven by higher gross prot partially oset by timing of marketing spend; Adjusted EBITDA margin 2 was 20.2%, a decrease of 70 basis points driven by investment in marketing noted above Strategic Partners Revenue decreased an expected 11.2% or $2.4 million, impacted by a reduction in business and the timing of onboarding new customer contracts amidst trade and tari uncertainties Gross prot was $2.4 million, consistent with Q3 2024; gross prot margin 3 increased by 170 basis points driven mainly by customer and product mix Adjusted EBITDA 1 was $1.5 million; Adjusted EBITDA margin 2 was 8.0%, an increase of 60 basis points, mainly due to customer and product mix Balance Sheet and Cash Flow from Operations All comparisons are with the third quarter of 2024 As at September 30, 2025, the Company had approximately $128.8 million in cash and available revolving and swingline facilities and net debt 1 of $371.2 million The Company generated $7.7 million in cash from operations compared to $24.2 million generated in Q3 2024 3

Page 4

Cash from operating activities before working capital considerations of $22.8 million was $4.3 million higher than Q3 2024 Cash invested in working capital increased by $20.8 million mainly due to increased inventories to support the high seasonality fourth quarter deliverables including growth of the business and securing supply amidst tari uncertainties and port congestion During the nine-month period ended September 30, 2025, the Company purchased for cancellation 636,284 common shares under its NCIB program for an aggregate consideration of $19.7 million 1This is a non-IFRS nancial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on eachnon-IFRS nancial measure.2This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.3This is a supplementary nancial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information oneach supplementary nancial measure. Narrowing Fiscal 2025 Outlook The Company’s 2025 investments in digital marketing and innovation continue to provide returns, and consumer consumption remains strong across each of our primary markets. As a result, the Company has narrowed its full year consolidated guidance for scal 2025, while maintaining the midpoint of its previous growth expectation for both revenue and Adjusted EBITDA. The Company now expects the following consolidated results: Revenue to range from $810.0 - $830.0 million or 10.4% - 13.1% growth (previously 9.0% - 14.5% growth) Adjusted EBITDA to range from $158.0 - $162.0 million or 12.0% - 15.0% growth (previously 11.0% - 15.5% growth) Adjusted Diluted EPS to range from $1.82 - $1.88 or 13.0% - 17.0% growth (previously 11.0% - 18.0% growth) The Company is adjusting its segment outlook for the 2025 scal year to reect higher Jamieson Brands revenue in China and youtheory, and lower Strategic Partners revenue to account for currency conversation and tari uncertainty related delays. The Company now expects the following segment results: Revenue in the Jamieson Brands segment to range from $710.0 - $725.0 million, or 12.9% - 15.3% growth (previously 10.5% - 15.3% growth) Canada revenue growth of 5.0% - 7.0% (previously 5.0% - 8.0% growth) youtheory revenue growth of 8.0% - 12.0% (previously 5.0% - 15.0% growth) 4

Page 5

China revenue growth of 45.0% - 50.0% (previously 30.0% - 40.0% growth) International revenue growth of 20.0% - 25.0% (previously 20% - 30% growth) Strategic Partners revenue to decline approximately 5.0% (previously up to 10.0%) The Company’s 2025 guidance reects the current prevailing trade environment between the United States, Canada and other countries. To date, taris have not had a material impact on the Company’s overall nancial performance, as a majority of these costs have been mitigated through our exible supply chain and operating eciencies. The Company recognizes that the trade environment is constantly changing, and actual results may be impacted by future changes in global trade policies. For additional details on the Company’s scal 2025 outlook, including guidance for the fourth quarter of 2025, refer to the “Outlook” section in the management’s discussion and analysis of nancial condition and results of operations (“MD&A”) for the three months ended September 30, 2025. Declaration of Third Quarter Dividend The board of directors of the Company declared a cash dividend for the third quarter of 2025 of $0.23 per common share, or approximately $9.6 million in total. Payable: December 15, 2025 Record date: December 1, 2025 Designated an “eligible dividend” under the Income Tax Act (Canada) Consolidated Financial Statements and Management’s Discussion and Analysis The Company’s unaudited condensed consolidated interim nancial statements and accompanying notes as at and for the three and nine months ended September 30, 2025 and related MD&A are available under the Company’s prole on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com. Conference Call Management will host a conference call to discuss the Company’s third quarter 2025 results at 5:00 p.m. ET today, November 6, 2025. To access: By phone: 1-800-717-1738 from Canada and the U.S. or 1-646-307-1865 from international locations Online: https://investors.jamiesonwellness.com or https://viavid.webcasts.com/starthere.jsp? ei=1738878&tp_key=18b6589547 5

Page 6

About Jamieson Wellness Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also oers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit jamiesonwellness.com. Jamieson Wellness’ head oce is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada. Forward-Looking Information This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and its outlook for its 2025 revenue, Adjusted EBITDA and Adjusted diluted earnings per share. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. This information reects the Company’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to dier materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2025 and under the “Risk Factors” section in the MD&A led today, November 6, 2025. This information is based on the Company’s reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. The Company cautions that the list of risk factors and uncertainties is not exhaustive and other factors could also adversely aect the Company’s results. Readers are urged to consider the risks, uncertainties and assumptions associated with these statements carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. See “Forward-looking Information” and “Risk Factors” within the MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements. 6

Page 7

Jamieson Wellness Inc. Selected Consolidated Financial InformationIn thousands of Canadian dollars, except share and per share amounts Three months ended Nine months ended September 30 September 30 2025 2024 2025 2024 Revenue 199,325 176,155 544,397 488,999 Cost of sales 115,710 108,584 324,748 313,615 Gross prot 83,615 67,571 219,649 175,384 Gross prot margin 41.9% 38.4% 40.3% 35.9% Selling, general and administrative expenses52,341 41,982 157,274 125,407 Share-based compensation 2,118 1,788 6,283 5,281 Earnings from operations29,156 23,80156,092 44,696 Operating margin 14.6% 13.5% 10.3% 9.1% Foreign exchange loss/(gain) 935 578 (310) (373)Interest expense and other nancing costs6,329 5,068 16,008 14,588 Accretion on preferred shares - 2,169 3,427 6,509 Earnings before income taxes 21,892 15,986 36,967 23,972 Provision for income taxes 6,379 5,568 10,140 8,960 Net earnings 15,513 10,418 26,827 15,012 Net earnings attributable to: Shareholders 14,979 10,564 25,604 15,104 Non-controlling interests 534 (146) 1,223 (92) 15,513 10,418 26,827 15,012Adjusted net earnings 17,679 15,834 40,894 34,403 EBITDA 33,09527,93471,01059,441 Adjusted EBITDA 37,969 33,914 92,135 81,566 Adjusted EBITDA margin19.0% 19.3% 16.9% 16.7% Weighted average number of shares Basic 41,819,27641,566,80541,836,51541,501,326Diluted 43,091,10842,943,97043,044,43042,747,176 Earnings per share attributable to commonshareholders: Basic, earnings per share 0.36 0.25 0.61 0.36 Diluted, earnings per share 0.35 0.24 0.59 0.35Adjusted diluted, earnings per share0.41 0.37 0.95 0.80 Jamieson Wellness Inc. Consolidated Statements of Financial PositionIn thousands of Canadian dollars September 30, 2025 December 31, 2024 Assets Current assets Cash 48,816 44,787Accounts receivable 151,593 228,031Inventories 236,645 154,658Derivatives 274 2,661Prepaid expenses and other current assets9,331 6,8031479 7

Page 8

Income taxes recoverable 1,479 - 448,138436,940Non-current assets Property, plant and equipment 112,861 103,591Goodwill 282,248 287,503Intangible assets 366,680 377,214 Deferred income tax 4,126 3,545 Total assets 1,214,0531,208,793 Liabilities Current liabilities Accounts payable and accrued liabilities 154,333 137,653Income taxes payable 1,532 4,373Derivatives 2,146 2,982 Current portion of other long-term liabilities17,687 27,673 175,698172,681Long-term liabilities Long-term debt 420,000 308,285Post-retirement benets 1,297 1,209Deferred income tax 63,133 64,467Redeemable preferred shares - 98,138 Other long-term liabilities 24,079 15,633 Total liabilities 684,207660,413 Equity Share capital 337,833 326,219Warrants 14,705 14,705Contributed surplus 25,051 23,835Retained earnings 82,669 99,109 Accumulated other comprehensive income25,840 41,313 Total shareholders' equity 486,098 505,181 Non-controlling interests 43,748 43,199 Total equity 529,846548,380 Total liabilities and equity 1,214,0531,208,793 Non-IFRS and Other Financial Measures This press release makes reference to certain nancial measures, including non-IFRS nancial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary nancial measures. Management uses these nancial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the protability of ongoing operations and in analyzing the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s nancial information reported under IFRS. The Company uses the following non-IFRS nancial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable nancial measure for each that is disclosed in its nancial statements being net earnings, “normalized gross prot”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable nancial measures for each that is disclosed in its nancial statements being gross prot, SG&A, earnings from operations, cash ows from operating activities, and long-term debt, respectively, the following non- 8

Page 9

IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross prot margin”, “normalized operating margin”, and the following supplementary nancial measures: “gross prot margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS nancial measures. Management also uses non-IFRS and supplementary nancial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS nancial measure to its most directly comparable nancial measure disclosed in the Company’s nancial statements to which the measure relates. The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross prot to normalized gross prot, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS nancial measures (see the “Non- IFRS and Other Financial Measures” of this press release for further information on each non-IFRS nancial measure) for the three and nine months ended September 30, 2025. Jamieson Wellness Inc. Segment InformationIn thousands of Canadian dollars, except as otherwise noted Jamieson Brands Three months ended September 30 2025 2024 $ Change %Change Revenue 180,523 154,988 25,535 16.5% Gross prot 81,253 65,257 15,996 24.5% Gross prot margin 45.0% 42.1% - 2.9% Share-based compensation (3) 2,118 1,788 330 18.5% Selling, general and administrative expenses50,815 40,516 10,299 25.4% Acquisition and divestiture related costs (2) - (541) 541 100.0% IT system implementation (4) (1,363) (2,992) 1,629 54.4% Legal and other(6) (458) (81) (377) (465.4%) Normalized selling, general and administrativeexpenses 48,994 36,902 12,092 32.8% Earnings from operations28,320 22,953 5,367 23.4% Acquisition and divestiture related costs (2) - 541 (541) (100.0%) IT system implementation (4) 1,363 2,992 (1,629) (54.4%) Legal and other (6) 458 81 377 465.4% Normalized earnings from operations30,141 26,567 3,574 13.5% Operating margin 15.7% 14.8% - 0.9%N lid i i 167% 171% (04%) 9

Page 10

Normalized operating margin16.7% 17.1% - (0.4%) Adjusted EBITDA 36,469 32,340 4,129 12.8%Adjusted EBITDA margin20.2% 20.9% - (0.7%) Strategic Partners Three months ended September 30 2025 2024 $ Change %Change Revenue 18,802 21,167 (2,365)(11.2%) Gross prot 2,362 2,314 48 2.1% Gross prot margin 12.6% 10.9% - 1.7% Selling, general and administrative expenses1,526 1,466 60 4.1% Earnings from operations836 848 (12) (1.4%) Operating margin 4.4% 4.0% - 0.4% Adjusted EBITDA 1,500 1,574 (74) (4.7%) Adjusted EBITDA margin8.0% 7.4% - 0.6% Jamieson Brands Nine months ended September 30 2025 2024 $ Change %Change Revenue 489,221 426,123 63,098 14.8% Gross prot 213,294 167,671 45,623 27.2% Labour relations costs(1) - 4,713 (4,713)(100.0%) IT system implementation (4) 1,023 - 1,023 100.0% Acquisition and divestiture related costs (2) - 165 (165) (100.0%) Normalized gross prot214,317 172,549 41,768 24.2% Gross prot margin 43.6% 39.3% - 4.3% Normalized gross prot margin43.8% 40.5% - 3.3% Share-based compensation(3) 6,283 5,281 1,002 19.0% Selling, general and administrative expenses152,622 120,839 31,783 26.3% Acquisition and divestiture related costs (2) - (865) 865 100.0% IT system implementation (4) (9,445) (9,421) (24) (0.3%) Labour relations costs(1) - (1,675) 1,675 100.0% Donations(5) (3,118) - (3,118)(100.0%) Legal and other (6) (1,340) (378) (962) (254.5%) Normalized selling, general and administrativeexpenses 138,719 108,500 30,21927.9% Earnings from operations54,389 41,551 12,838 30.9% Acquisition and divestiture related costs (2) - 1,030 (1,030) (100.0%) IT system implementation (4) 10,468 9,421 1,047 11.1% Labour relations costs(1) - 6,388 (6,388) (100.0%) Donations(5) 3,118 - 3,118 100.0% Legal and other (6) 1,340 378 962 254.5% Normalized earnings from operations69,315 58,768 10,547 17.9% O i i 111% 98% 13% 10

Page 11

Operating margin 11.1% 9.8% - 1.3% Normalized operating margin14.2% 13.8% - 0.4% Adjusted EBITDA 88,197 76,155 12,042 15.8% Adjusted EBITDA margin18.0% 17.9% - 0.1% Strategic Partners Nine months ended September 30 2025 2024 $ Change %Change Revenue 55,176 62,876 (7,700)(12.2%) Gross prot 6,355 7,713 (1,358) (17.6%) IT system implementation (4) 226 - 226 100.0% Normalized gross prot6,581 7,713 (1,132) (14.7%) Gross prot margin 11.5% 12.3% - (0.8%) Normalized gross prot margin11.9% 12.3% - (0.4%) Selling, general and administrative expenses4,652 4,568 84 1.8% Earnings from operations1,703 3,145 (1,442) (45.9%) IT system implementation (4) 226 - 226 100.0% Normalized earnings from operations1,929 3,145 (1,216) (38.7%) Operating margin 3.1% 5.0% - (1.9%) Normalized operating margin3.5% 5.0% - (1.5%) Adjusted EBITDA 3,938 5,411 (1,473) (27.2%) Adjusted EBITDA margin7.1% 8.6% - (1.5%) Reconciliation of Non-IFRS Financial Measures In thousands of Canadian dollars Three months ended Nine months ended September 30 September 30 2025 2024 2025 2024 Net earnings: 15,513 10,41826,827 15,012 Add:Recovery of income taxes 6,379 5,568 10,140 8,960Interest expense and other nancing costs6,329 5,068 16,008 14,588Accretion on preferred shares - 2,169 3,427 6,509 Depreciation of property, plant, and equipment3,419 3,201 10,148 9,953 Amortization of intangible assets1,455 1,510 4,460 4,419 Earnings before interest, taxes, depreciation, andamortization (EBITDA) 33,09527,93471,01059,441 Share-based compensation (3) 2,118 1,788 6,283 5,281Foreign exchange loss/(gain) 935 578 (310) (373)Labour relations costs(1) - - - 6,388IT system implementation (4) 1,363 2,992 10,694 9,421Acquisition and divestiture related costs (2) - 541 - 1,030Donations(5) - - 3,118 - Legal and other(6) 458 81 1,340 378 Adjusted EBITDA 37,96933,91492,13581,566 Recovery of income taxes (6,379) (5,568)(10,140)(8,960)Interest expense and other nancing costs(6,329) (5,068)(16,008)(14,588)Depreciation of property, plant, and equipment(3,419) (3,201)(10,148)(9,953)A i i fi ibl (1455) (1510) (4460) (4419) 11

Page 12

Amortization of intangible assets(1,455) (1,510) (4,460) (4,419)Share-based compensation (3) (1,996) (1,666) (5,917) (4,915)Tax deduction from vesting of certain share-based awards- - (708) - Tax eect of normalization adjustments(712) (1,067) (3,860) (4,328) Adjusted net earnings 17,67915,83440,89434,403 Three months ended Nine months ended September 30 September 30 2025 2024 2025 2024 Gross prot 83,615 67,571219,649175,384 Labour relations costs(1) - - - 4,713Acquisition and divestiture related costs (2) - - - 165 IT system implementation (4) - - 1,249 - Normalized gross prot83,61567,571220,898180,262 Normalized gross prot margin41.9% 38.4% 40.6% 36.9%Selling, general and administrative expenses52,341 41,982157,274125,407 Acquisition and divestiture related costs (2) - (541) - (865)IT system implementation (4) (1,363) (2,992) (9,445) (9,421)Labour relations costs(1) - - - (1,675)Donations(5) - - (3,118) - Legal and other (6) (458) (81) (1,340) (378) Normalized selling, general and administrative expenses50,52038,368143,371113,068 Earnings from operations29,15623,80156,09244,696 Acquisition and divestiture related costs (2) - 541 - 1,030IT system implementation (4) 1,363 2,992 10,694 9,421Donations(5) - - 3,118 -Labour relations costs(1) - - - 6,388 Legal and other(6) 458 81 1,340 378 Normalized earnings from operations30,97727,41571,24461,913 Normalized operating margin15.5% 15.6% 13.1% 12.7% (1)These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer nes and penalties, along withfreight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024.(2)Prior year expenses mainly pertain to legal, consulting and integration costs associated with the acquisition and integration of our formerdistributor partner in China on April 28, 2023.(3)The Company’s share-based compensation expense pertains to our long-term incentive plan (the “LTIP”) (refer to “Share-based compensation”),with stock options, performance-based share units (“PSUs”), time-based restricted share units (“RSUs”), and deferred share units (“DSUs”)expenses, along with associated payroll taxes.(4)Mainly pertains to development costs associated with our IT system implementation to augment our system infrastructure. Unlike other systemimprovement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.(5)Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildres.(6)Includes other non-recurring expenses primarily related to non-operational legal costs. Reconciliation of Net Debt In thousands of Canadian dollars ($ in 000's) As at September30, As at December31,2025 2024 Long-term debt 420,000 308,285 Cash (48,816) (44,787) Net debt 371,184263,498 Investor and Media Contact Information: Jamieson Wellness 12

Page 13

Ruth Winker 416-960-0052 rwinker@jamiesonlabs.com Source: Jamieson Wellness Inc. 13

Earnings release